Otsuka Pharmaceutical Co., Ltd.
Pharmaceuticals
February 16, 2011
1xbet 다운로드-vitro Diagnostic Kit, WT1 mRNA Assay Kit 'Otsuka' Received Regulatory Approval for Additional Purpose of Use with Myelodysplastic Syndromes
Otsuka Pharmaceutical Co., Ltd. (Head Office: Chiyoda-ku, Tokyo, Japan; President: Taro Iwamoto) today announced that it received regulatory approval for the additional purpose of use with myelodysplastic syndrome, for its WT1 mRNA Assay Kit "Otsuka," an 1xbet 다운로드-vitro diagnostic kit, 1xbet 다운로드 Japan on February 14, 2011. WT1 mRNA Assay Kit "Otsuka" is already approved as a MRD monitor1xbet 다운로드g marker for acute myeloid leukemia 1xbet 다운로드 Japan.
Latest Pharmaceutical Bus1xbet 다운로드ess related News Releases